1. Home
  2. News
  3. Cynata Therapeutics Limited
  4. Successful Completion of Planned DSMB Review of DFU Trial
More Cynata Therapeutics Limited news
Cynata Therapeutics LimitedASX: CYP

Successful Completion of Planned DSMB Review of DFU Trial

Oct 11, 2022 at 10:47 PM EDT · Issued by Cynata Therapeutics Limited

Filed with ASX · Oct 11, 2022 at 10:47 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/successful-completion-of-planned-dsmb-review-of-dfu-trial

Cynata Therapeutics Limited on 6ix

Story so far

  • Completion of Entitlement Offer and Shortfall PlacementJan 18, 2021

Earlier from Cynata Therapeutics

  • Grant Award to Fund Study of Cynata MSCs in Heart DiseaseSep 25, 2022
  • Pipeline Update Following Strategic Portfolio ReviewAug 11, 2022
  • Further data supports potency of Cynata MSCsJun 13, 2022
  • FDA Clears Cynata IND for Phase 2 Trial in GvHDMay 26, 2022
  • Notice of Allowance for Cynata Chinese PatentFeb 27, 2022

Later from Cynata Therapeutics

  • Notice of Allowance for Australia & Canada Cymerus PatentsOct 16, 2022
  • New Kidney Transplantation Clinical Trial for Cynata & LUMCNov 1, 2022
  • Notice of Allowance for Cynata US PatentNov 10, 2022
  • Cynata Receives $1.65m R&D Tax Incentive RefundDec 4, 2022
  • Notice of Acceptance for Cynata Australian PatentJan 9, 2023
All Cynata Therapeutics news releases↗

Follow Cynata Therapeutics into a list and get an email when it puts out news.

Follow Cynata Therapeutics
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer